Diametric Capital’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-1,741
Closed -$210K – 318
2022
Q3
$210K Buy
1,741
+1
+0.1% +$120 0.11% 216
2022
Q2
$134K Buy
1,740
+433
+33% +$43.4K 0.1% 219
2022
Q1
$203K Buy
1,307
+589
+82% +$99.3K 0.11% 186
2021
Q4
$173K Buy
718
+219
+44% +$72.4K 0.13% 139
2021
Q3
$214K Sell
499
-75
-13% -$34.4K 0.17% 112
2021
Q2
$313K Buy
+574
New +$252K 0.23% 97

Other funds holding KRSA

Diametric Capital's KRSA Position: Q4 2022 in Review

Diametric Capital sold out of Korsana Biosciences (KRSA) in Q4 2022, closing a stake of 1,741 shares — an estimated $210K sold.

Diametric Capital first reported a position in KRSA in Q2 2021 and held it in 6 quarters. The position peaked at $313K in Q2 2021. 33 funds tracked by Wall St. Rank hold KRSA as of Q4 2022.

  • Diametric Capital reported no remaining Korsana Biosciences position as of Q4 2022 after selling out during the quarter.
  • Diametric Capital sold 1,741 Korsana Biosciences shares in Q4 2022, an estimated $210K.
  • Diametric Capital first reported a position in Korsana Biosciences in Q2 2021 and held it in 6 quarters.
  • Diametric Capital's Korsana Biosciences position peaked at $313K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Korsana Biosciences as of Q4 2022.

Based on Diametric Capital's 13F filing for Q4 2022, filed 29 Mar 2023.